atezolizumab
rs oncology,roche
['atezo', 'renal,(-adrenal)', 'immotion010', 'rs onco']
#esmo22 news: immotion010 does not support adjuvant atezolizumab for renal cell carcinoma at increased risk of recurrence. read more about the phase 3 data presented by axel bex on behalf of &amp; fellow investigators 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.